354 



INDEX 



Bacillus acidi lactici in bacterin 



therapy, 277, 293 

 acnes in bacterin therapy, 260 

 anthracis in bacterin therapy, 262, 



266 

 coli in bacterin therapy, 262, 266, 



273, 276, 277, 279, 280, 284, 290 

 diphtherise in bacterin therapy, 



285, 286 

 dysenterise in bacterin therapy, 



298 

 fluorescens in bacterin therapy, 



266, 284 

 influenzae in bacterin therapy, 



285, 286, 290, 292, 299 

 Koch- Weeks in bacterin therapy, 



283 

 lactis aerogenes in bacterin 



therapy, 266, 284 

 lactis bulgaricus in bacterin ther- 

 apy, 304 

 mallei in bacterin therapy, 262, 



268 

 Morax - Axenfeld in bacterin 



therapy, 283 

 of Bordet-Gengou in bacterin ther- 

 apy, 292 

 of Friedlander in bacterin therapy, 



273, 283 

 pestis in bacterin therapy, 271 

 prodigiosus in bacterin therapy, 



303 

 proteus vulgaris in bacterin 



therapy, 266, 284 

 pseudodiphtherise in bacterin 



therapy, 285, 291 

 pseudotuberculosis rodentium in 



bacterin therapy, 273 

 pyocyaneus in bacterin therapy, 



262, 266, 277, 283, 284, 293 

 tuberculosis in bacterin therapy, 



262, 266, 273, 280, 283, 284, 



285, 292, 293 

 typhosus in bacterin therapy, 262, 



273, 277, 280, 285, 293 

 Bacterisemia, bacterin therapy in, 298 

 Bacterial infections, natural recovery 



from, 213 

 Bacterial inoculation, 216 



general indications for, 242 

 Bacterial suspensions, standardization 



of, 219 

 Bacterin therapy, accessory measures 

 in, 258 

 causes of failure, 255 



Bacterin therapy, contra-indications, 

 254 

 in various diseases, 259-298 

 limitations, 255 

 opsonic control of, 225 

 results of, 259 



stock versus autogenous bac- 

 terins, 256 

 Bacterins, autogenous vs. stock, 224 

 autolysis of, 221 



clinical symptoms in administra- 

 tion of, 225 

 containers for, 223 

 dosage of, 250 

 standardization of, 219 

 technic of administration of, 248 

 Bacteriocidin, 214 

 Bacteriolysins, 21, 86 

 Blood, medico-legal identification of, 



83, 85 

 Bordet-Gengou phenomenon, 92 

 Bubonic plague, bacterin therapy in, 

 271 



Cancer, inoculation treatment of, 302 

 Carbunculosis, bacterin therapy in, 



261 

 Carcinoma, meiostagmin reaction in, 

 163 

 sera and extracts in, 67 

 Cellulitis, bacterin therapy in, 265 

 Cerebrospinal meningitis, bacterin 



therapy in, 300 

 Chemotherapy, 318 

 Cholera, bacterin therapy in, 298 

 Cholesterinizod extracts in Wasser- 



mann reaction, 96 

 Coagulose, 307 

 Coley's fluid, 302 

 Complement, 86 



fixation reaction, 16 



gonococcus, 141 



in echinococcus disease, 



153 

 in proteid differentia- 

 tion, 155 

 in tuberculosis, 154 

 in typhoid fever, 154 

 Complement, preparation of, 116 



titration of, 117 

 Corneal ulcer, bacterin therapy in, 284 

 Corpus luteum, 316 

 Corynebacterium pseudodiphtheriti- 



cum in bacterin therapy, 277 

 Cretinism, thyroid in, 312 



